Filed 1mo ago· Apr 14, 2026
26 days to disclose
John Boozman
RSenateArkansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 176
Filed 2mo ago· Mar 25, 2026
50 days to disclose · 5 past 45-day window
Susan M. Collins
RSenateMaine
↑bought
Pfizer
PFE
$15K-$50K
Trade dateFeb 3, 2026
Bond⚑ Pharmaceutical
Filed 2mo ago· Mar 24, 2026
39 days to disclose
Angus S., Jr. King
ISenateMaine
↓sold
Eli Lilly
LLY
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 13, 2026
Filed 4mo ago· Jan 26, 2026
28 days to discloseAngus S., Jr. King
ISenateMaine
↑bought
Eli Lilly
LLY
$1K-$15K
+3.8% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 16, 2026
18 days to disclose
Markwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
+2.5% vs S&P 500
Trade dateDec 29, 2025
Filed 5mo ago· Dec 8, 2025
17 days to discloseJohn Boozman
RSenateArkansas
↓sold
Eli Lilly
LLY
$1K-$15K
−3.9% vs S&P 500
Trade dateNov 21, 2025
Filed 6mo ago· Dec 5, 2025
25 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$15K-$50K
+0.8% vs S&P 500
Trade dateNov 10, 2025
Filed 7mo ago· Nov 4, 2025
11 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↑bought
Eli Lilly
LLY
$1K-$15K
+26.2% vs S&P 500
Trade dateOct 24, 2025
⚑ Pharmaceutical
Filed 8mo ago· Oct 3, 2025
29 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↓sold
Amgen
AMGN
$1K-$15K
+8.1% vs S&P 500
Trade dateSep 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+40.8% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+7.5% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+14.0% vs S&P 500
Trade dateAug 11, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+52.2% vs S&P 500
Trade dateAug 11, 2025
Filed 9mo ago· Aug 12, 2025
244 days to disclose · 199 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$50K-$100K
+28.1% vs S&P 500
Trade dateDec 11, 2024
Filed 9mo ago· Aug 12, 2025
496 days to disclose · 451 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$1K-$15K
+65.7% vs S&P 500
Trade dateApr 3, 2024
Filed 9mo ago· Aug 12, 2025
586 days to disclose · 541 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 9mo ago· Aug 12, 2025
586 days to disclose · 541 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 11mo ago· Jul 2, 2025
29 days to disclose
Ron Wyden
DSenateOregon
↓sold
Pfizer
PFE
$1K-$15K
+11.6% vs S&P 500
Trade dateJun 3, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 11mo ago· Jun 11, 2025
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$50K-$100K
−65.0% vs S&P 500
Trade dateMay 13, 2025
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
28 days to discloseJohn Boozman
RSenateArkansas
↓sold
Gilead Sciences
GILD
$1K-$15K
+9.0% vs S&P 500
Trade dateApr 16, 2025
Filed 1.1y ago· May 12, 2025
34 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$15K-$50K
+11.7% vs S&P 500
Trade dateApr 8, 2025
Filed 1.2y ago· Mar 6, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↓sold
Pfizer
PFE
$1K-$15K
+1.4% vs S&P 500
Trade dateFeb 13, 2025
Filed 1.3y ago· Feb 21, 2025
11 days to discloseRon Wyden
DSenateOregon
↓sold
Eli Lilly
LLY
$50K-$100K
+1.5% vs S&P 500
Trade dateFeb 10, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 21, 2025
30 days to discloseRon Wyden
DSenateOregon
↑bought
Eli Lilly
LLY
$50K-$100K
+37.4% vs S&P 500
Trade dateJan 22, 2025
⚑ Pharmaceutical
Filed 1.6y ago· Nov 15, 2024
17 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$15K-$50K
Trade dateOct 29, 2024
⚑ Pharmaceutical
Filed 1.6y ago· Nov 7, 2024
8 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
+33.9% vs S&P 500
Trade dateOct 30, 2024
⚑ Pharmaceutical
Filed 1.6y ago· Oct 10, 2024
23 days to discloseSheldon Whitehouse
DSenateRhode Island
↓sold
Amgen
AMGN
$1K-$15K
+23.3% vs S&P 500
Trade dateSep 17, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 21, 2024
49 days to disclose · 4 past 45-day windowSheldon Whitehouse
DSenateRhode Island
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+3.6% vs S&P 500
Trade dateJul 3, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 21, 2024
49 days to disclose · 4 past 45-day windowSheldon Whitehouse
DSenateRhode Island
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+3.6% vs S&P 500
Trade dateJul 3, 2024
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−62.8% vs S&P 500
Trade dateMay 8, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+32.4% vs S&P 500
Trade dateMay 3, 2024
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Pfizer
PFE
$15K-$50K
+42.5% vs S&P 500
Trade dateMay 3, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.0y ago· May 20, 2024
41 days to discloseSheldon Whitehouse
DSenateRhode Island
↓sold
Novartis Ag
NVS
$1K-$15K
−14.4% vs S&P 500
Trade dateApr 9, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
40 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+49.7% vs S&P 500
Trade dateApr 5, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
41 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+58.9% vs S&P 500
Trade dateApr 4, 2024
Regeneron Pharmaceuticals, Inc. -
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+24.9% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+23.5% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−46.5% vs S&P 500
Trade dateApr 3, 2024
Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↑bought
AbbVie
ABBV
$1K-$15K
−25.4% vs S&P 500
Trade dateApr 3, 2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−24.9% vs S&P 500
Trade dateApr 3, 2024
Option⚑ Pharmaceutical
Filed 2.1y ago· May 2, 2024
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$1K-$15K
+65.7% vs S&P 500
Trade dateApr 3, 2024
Filed 2.1y ago· May 1, 2024
28 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$1K-$15K
+65.7% vs S&P 500
Trade dateApr 3, 2024
Filed 2.2y ago· Mar 15, 2024
17 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−40.4% vs S&P 500
Trade dateFeb 27, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.2y ago· Mar 15, 2024
17 days to discloseShelley Moore Capito
RSenateWest Virginia
↑bought
Zoetis
ZTS
$15K-$50K
−82.1% vs S&P 500
Trade dateFeb 27, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Novo Nordisk
NVO
$15K-$50K
+109.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.2% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+40.0% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 26, 2024
22 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 2.4y ago· Jan 26, 2024
22 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 2.4y ago· Jan 18, 2024
35 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$1K-$15K
+2.8% vs S&P 500
Trade dateDec 14, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 18, 2024
38 days to discloseSheldon Whitehouse
DSenateRhode Island
↓sold
Pfizer
PFE
$1K-$15K
+11.7% vs S&P 500
Trade dateDec 11, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 17, 2024
34 days to disclose
Jerry Moran
RSenateKansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateDec 14, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 17, 2024
34 days to discloseJerry Moran
RSenateKansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateDec 14, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 17, 2024
34 days to discloseJerry Moran
RSenateKansas
↓sold
Pfizer
PFE
$1K-$15K
+9.8% vs S&P 500
Trade dateDec 14, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.4y ago· Jan 12, 2024
25 days to discloseShelley Moore Capito
RSenateWest Virginia
↓sold
Pfizer
PFE
$1K-$15K
+10.3% vs S&P 500
Trade dateDec 18, 2023
⚑ Pharmaceutical
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
Filed 2.5y ago· Dec 15, 2023
25 days to discloseTommy Tuberville
RSenateAlabama
↓sold
AbbVie
ABBV
$1K-$15K
+61.9% vs S&P 500
Trade dateNov 20, 2023
Option⚑ Pharmaceutical
Filed 2.5y ago· Dec 15, 2023
29 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+61.9% vs S&P 500
Trade dateNov 16, 2023
Option⚑ Pharmaceutical
Filed 2.6y ago· Nov 16, 2023
30 days to discloseTommy Tuberville
RSenateAlabama
↑bought
AbbVie
ABBV
$1K-$15K
−30.5% vs S&P 500
Trade dateOct 17, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 16, 2023
30 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−16.1% vs S&P 500
Trade dateOct 17, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Merck
MRK
$1K-$15K
+13.2% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+19.3% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
GSK PLC
GSK
$1K-$15K
+14.9% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 2, 2023
29 days to disclose
Thomas R Carper
DSenateDelaware
↑bought
Revance Therapeutics, Inc. -
RVNC
$1K-$15K
Trade dateOct 4, 2023
Filed 2.6y ago· Nov 2, 2023
29 days to discloseThomas R Carper
DSenateDelaware
↓sold
Structure Therapeutics
GPCR
$1K-$15K
Trade dateOct 4, 2023
Filed 2.6y ago· Nov 1, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−100.7% vs S&P 500
Trade dateOct 3, 2023
Filed 2.6y ago· Nov 1, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$1K-$15K
−1.0% vs S&P 500
Trade dateOct 3, 2023
Filed 2.6y ago· Oct 20, 2023
29 days to disclose
Pete Ricketts
RSenateNebraska
↓sold
Johnson & Johnson
JNJ
$100K-$250K
+24.8% vs S&P 500
Trade dateSep 21, 2023
Filed 2.6y ago· Oct 20, 2023
29 days to disclosePete Ricketts
RSenateNebraska
↓sold
Merck
MRK
$50K-$100K
+13.9% vs S&P 500
Trade dateSep 21, 2023
Filed 2.6y ago· Oct 17, 2023
27 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
−7.6% vs S&P 500
Trade dateSep 20, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 17, 2023
27 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Novartis Ag
NVS
$15K-$50K
−22.3% vs S&P 500
Trade dateSep 20, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 13, 2023
35 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 12, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$15K-$50K
−95.7% vs S&P 500
Trade dateSep 13, 2023
Filed 2.6y ago· Oct 12, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
−12.3% vs S&P 500
Trade dateSep 13, 2023
Filed 2.7y ago· Oct 4, 2023
21 days to disclose
John R. Curtis
RSenateUtah
↑bought
Eli Lilly
LLY
$1K-$15K
−12.3% vs S&P 500
Trade dateSep 13, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Oct 4, 2023
21 days to discloseJohn R. Curtis
RSenateUtah
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+29.2% vs S&P 500
Trade dateSep 13, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Oct 3, 2023
40 days to discloseSheldon Whitehouse
DSenateRhode Island
↔exchanged
Johnson & Johnson
JNJ
$1K-$15K
Trade dateAug 24, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Oct 3, 2023
40 days to discloseSheldon Whitehouse
DSenateRhode Island
↔exchanged
Johnson & Johnson
JNJ
$1K-$15K
Trade dateAug 24, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 22, 2023
31 days to disclose
Dan Sullivan
RSenateAlaska
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+25.9% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 22, 2023
31 days to discloseDan Sullivan
RSenateAlaska
↓sold
Zoetis
ZTS
$1K-$15K
+98.7% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 22, 2023
31 days to discloseDan Sullivan
RSenateAlaska
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+68.0% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 18, 2023
27 days to discloseDan Sullivan
RSenateAlaska
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+68.0% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 18, 2023
27 days to discloseDan Sullivan
RSenateAlaska
↓sold
Zoetis
ZTS
$1K-$15K
+98.7% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 18, 2023
27 days to discloseDan Sullivan
RSenateAlaska
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+25.9% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 5, 2023
11 days to discloseThomas R Carper
DSenateDelaware
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+126.6% vs S&P 500
Trade dateAug 25, 2023
Intellia Therapeutics, Inc. -
Filed 2.8y ago· Aug 14, 2023
20 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Pfizer
PFE
$1K-$15K
−83.9% vs S&P 500
Trade dateJul 25, 2023
Pfizer, Inc.
⚑ Pharmaceutical
Filed 2.9y ago· Jul 26, 2023
238 days to disclose · 193 past 45-day windowDan Sullivan
RSenateAlaska
↑bought
Zoetis
ZTS
$1K-$15K
−99.3% vs S&P 500
Trade dateNov 30, 2022
⚑ Pharmaceutical
Filed 2.9y ago· Jul 26, 2023
238 days to disclose · 193 past 45-day windowDan Sullivan
RSenateAlaska
↓sold
Elanco Animal Health
ELAN
$1K-$15K
−1.6% vs S&P 500
Trade dateNov 30, 2022
⚑ Pharmaceutical
Filed 2.9y ago· Jul 17, 2023
35 days to discloseShelley Moore Capito
RSenateWest Virginia
↓sold
Amgen
AMGN
$1K-$15K
+6.1% vs S&P 500
Trade dateJun 12, 2023
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 14, 2026 1mo ago | John Boozman RSenateArkansas | ↓sold | Johnson & Johnson JNJ | Mar 19, 2026 26 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 25, 2026 2mo ago | Susan M. Collins RSenateMaine | ↑bought | Pfizer PFE Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 3, 2026 50 days to disclose · 5 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Mar 24, 2026 2mo ago | Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 8, 2025 5mo ago | John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Nov 10, 2025 25 days to disclose | Flat·+0.0% +0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 4, 2025 7mo ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 24, 2025 11 days to disclose | Good buy·+$2.2K+27.9% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2025 8mo ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 4, 2025 29 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 22, 2025 21 days to disclose | Flat·+0.0% +7.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 11, 2025 32 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 11, 2024 244 days to disclose · 199 past 45-day window | Good buy·+$24.4K+32.6% +28.1% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 3, 2024 496 days to disclose · 451 past 45-day window | Smart sell·+$2.3K+28.3% +65.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 586 days to disclose · 541 past 45-day window | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 586 days to disclose · 541 past 45-day window | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 2, 2025 11mo ago | Ron Wyden DSenateOregon | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Finance | Jun 3, 2025 29 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | May 13, 2025 29 days to disclose | Bad buy·−$39.3K-52.4% −65.0% vs S&P 500 | $50K-$100K midpoint $75K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | John Boozman RSenateArkansas | ↓sold | Gilead Sciences GILD | Apr 16, 2025 28 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 8, 2025 34 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 6, 2025 1.2y ago | John Boozman RSenateArkansas | ↓sold | Pfizer PFE | Feb 13, 2025 21 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Feb 10, 2025 11 days to disclose | Flat·+0.0% +1.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Jan 22, 2025 30 days to disclose | Good buy·+$31.4K+41.9% +37.4% vs S&P 500 | $50K-$100K midpoint $75K |
Nov 15, 2024 1.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 29, 2024 17 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Nov 7, 2024 1.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 30, 2024 8 days to disclose | Good buy·+$11.1K+34.1% +33.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2024 1.6y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 17, 2024 23 days to disclose | Missed gain·−$282-3.5% +23.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jul 3, 2024 49 days to disclose · 4 past 45-day window | Flat·+0.0% +3.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 21, 2024 1.8y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jul 3, 2024 49 days to disclose · 4 past 45-day window | Flat·+0.0% +3.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Missed gain·−$8.1K-100.9% −62.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Vertex Pharmaceuticals VRTX ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Missed gain·−$583-7.3% +32.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Smart sell·+$947+2.9% +42.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 20, 2024 2.0y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Apr 9, 2024 41 days to disclose | Missed gain·−$4.1K-51.8% −14.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 5, 2024 40 days to disclose | Good buy·+$7K+87.4% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Regeneron Pharmaceuticals REGN Regeneron Pharmaceuticals, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 4, 2024 41 days to disclose | Smart sell·+$1.6K+19.8% +58.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$1K-12.5% +24.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$6.7K-83.9% −46.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$965+12.1% −25.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$1K+12.5% −24.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2024 2.1y ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 3, 2024 29 days to disclose | Smart sell·+$2.3K+28.3% +65.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 1, 2024 2.1y ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 3, 2024 28 days to disclose | Smart sell·+$2.3K+28.3% +65.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 15, 2024 2.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Feb 27, 2024 17 days to disclose | Flat·+0.4% −40.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 15, 2024 2.2y ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Feb 27, 2024 17 days to disclose | Bad buy·−$13.4K-41.3% −82.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Smart sell·+$20K+61.5% +109.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Missed gain·−$981-12.3% +40.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2024 2.4y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 22 days to disclose | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2024 2.4y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 22 days to disclose | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 18, 2024 2.4y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 35 days to disclose | Good buy·+$4.3K+54.1% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 18, 2024 2.4y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 11, 2023 38 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | Jerry Moran RSenateKansas | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | Jerry Moran RSenateKansas | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | Jerry Moran RSenateKansas | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2024 2.4y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Pfizer PFE ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 18, 2023 25 days to disclose | Flat·+0.0% +10.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 20, 2023 25 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 16, 2023 29 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Good buy·+$2.7K+33.2% −30.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Bad buy·−$220-2.7% −16.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Flat·+0.0% +13.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.6K-44.4% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.9K-48.8% +14.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 2, 2023 2.6y ago | Thomas R Carper DSenateDelaware | ↑bought | Revance Therapeutics, Inc. - RVNC | Oct 4, 2023 29 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 2, 2023 2.6y ago | Thomas R Carper DSenateDelaware | ↓sold | Structure Therapeutics GPCR | Oct 4, 2023 29 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Oct 3, 2023 29 days to disclose | Bad buy·−$2.5K-31.4% −100.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Oct 3, 2023 29 days to disclose | Good buy·+$5.5K+68.3% −1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2023 2.6y ago | Pete Ricketts RSenateNebraska | ↓sold | Johnson & Johnson JNJ | Sep 21, 2023 29 days to disclose | Missed gain·−$71.3K-40.7% +24.8% vs S&P 500 | $100K-$250K midpoint $175K |
Oct 20, 2023 2.6y ago | Pete Ricketts RSenateNebraska | ↓sold | Merck MRK | Sep 21, 2023 29 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $50K-$100K midpoint $75K |
Oct 17, 2023 2.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$17.9K+55.2% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 17, 2023 2.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$13.1K+40.4% −22.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 13, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Sep 13, 2023 29 days to disclose | Bad buy·−$11.6K-35.8% −95.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Sep 13, 2023 29 days to disclose | Good buy·+$15.5K+47.6% −12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | John R. Curtis RSenateUtah | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.8K+47.6% −12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 4, 2023 2.7y ago | John R. Curtis RSenateUtah | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.3K+41.1% +29.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | Sheldon Whitehouse DSenateRhode Island | ↔exchanged | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 24, 2023 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | Sheldon Whitehouse DSenateRhode Island | ↔exchanged | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 24, 2023 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 22, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 31 days to disclose | Missed gain·−$3K-37.0% +25.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 22, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 31 days to disclose | Smart sell·+$2.9K+35.7% +98.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 22, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 31 days to disclose | Smart sell·+$407+5.1% +68.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 18, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 27 days to disclose | Smart sell·+$407+5.1% +68.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 18, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 27 days to disclose | Smart sell·+$2.9K+35.7% +98.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 18, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 27 days to disclose | Missed gain·−$3K-37.0% +25.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 5, 2023 2.7y ago | Thomas R Carper DSenateDelaware | ↓sold | Intellia Therapeutics NTLA Intellia Therapeutics, Inc. - | Aug 25, 2023 11 days to disclose | Smart sell·+$5.1K+64.4% +126.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2023 2.8y ago | Tommy Tuberville RSenateAlabama | ↑bought | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jul 25, 2023 20 days to disclose | Bad buy·−$2.2K-27.1% −83.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 26, 2023 2.9y ago | Dan Sullivan RSenateAlaska | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Nov 30, 2022 238 days to disclose · 193 past 45-day window | Bad buy·−$1.9K-24.2% −99.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 26, 2023 2.9y ago | Dan Sullivan RSenateAlaska | ↓sold | Elanco Animal Health ELAN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Nov 30, 2022 238 days to disclose · 193 past 45-day window | Missed gain·−$6.1K-76.8% −1.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 17, 2023 2.9y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jun 12, 2023 35 days to disclose | Missed gain·−$4.7K-58.5% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |